NCT05189054View on ClinicalTrials.gov

Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2027

Conditions
Stereotactic Body Radiation TherapyIrradiation; ReactionThoracic TumorRecurrent Cancer
Interventions
RADIATION

stereotacitic body radiation therapy

The patients were treated with high-dose and low fractionated radiotherapy, using modern precision radiotherapy technology.

Trial Locations (1)

100191

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER